期刊文献+

慢性心力衰竭患者血浆B型钠尿肽联合红细胞分布宽度及血小板分布宽度检测的临床意义 被引量:9

下载PDF
导出
摘要 慢性心力衰竭(CHF)是多种心血管事件如急性冠状动脉综合征、心肌病、高血压病、心脏瓣膜疾病等发展至一定严重程度的终末转归。近年来,CHF患病率大为激增,致病机制又极其复杂,治疗手段进展缓慢,预后往往不良。血浆B型利钠肽(BNP)可反映CHF患者心脏收缩和舒张功能,是CHF早期诊断、风险评估及预后判断的有效指标。
作者 缪亚梅 金梅
出处 《实用临床医药杂志》 CAS 2013年第23期145-146,共2页 Journal of Clinical Medicine in Practice
  • 相关文献

参考文献8

  • 1Nishikimi T. Clinical significance of BNP as a biomarker for cardiac disease - from a viewpoint of basic science and clinical aspect[J]. Nihon Rinsho, 2012,70(5) :774.
  • 2Cauthen CA, Tong W, lain A, et al. Progressive rise in red cell distribution width is associated with disease progression in ambulatory patients with chronic heart failure[J]. J Card Fail, 2012, 18(2):146.
  • 3Wiwanitkit V. Plateletcrit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parametersUJ. Clin Appl Thromb Hemost, 2004, 10(2):175.
  • 4Farmakis D, Parissis J T, Bistola V, et al. Plasma B- type natriuretic peptide reduction predicts long - term response to levosimendan therapy in acutely decompensated chronic heart failure[J]. Int J Cardiol, 2010,139 (1): 75.
  • 5Clerico A, Vittorini S, Passino C. Circulating forms of the b - type natriuretic peptide prohormone: pathophysiologic and clinical considerations[J]. Adv Clin Chem, 2012, 58: 3l.
  • 6Van Craenenbroeck E M, Pelle AJ, Beckers PJ. et al. Red cell distribution width as a marker of impaired exercise tolerance in patients with chronic heart failure [J]. Eur J Heart Fail,2012,14(1):54.
  • 7Allen L A, Felker G M, Mehra M R, et al. Validation and potential mechanisms of red cell distribution width as a prognosticmarker in heart failure[J].J Card Fail, 2010,16(3): 230.
  • 8Pasic J, Sullivan M D, Russo J, et at. Lack of depression effect on platelet activation in patients with heart failure [J]. Psychiatry Res, 2004, 129(3): 289.

同被引文献101

  • 1Borensztajn K, Crestani B, Kolb M, et al. Idiopathic pulmonary fibro- sis : from epithelial injury to biomarkers- insights from the bench side [ J]. Respiration,2013,86:441 -452.
  • 2Ohnishi H, Yokoyama A, Kondo K, et al. Comparative study of KL- 6, surfactant protein-A, surfactant protein-D, and monocyte chemoat- tractant protein-1 as serum markers for interstitial lung diseases[ J]. Am J Respir Crit Care Med,2002,165:378 - 381.
  • 3Satoh H, Kurishima K, Ishikawa H, et al. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases [ J]. J Intern Med ,2006,260:429 -434.
  • 4Ishii H, Mukae H, Kadota J, et al. High serum concentrations of sur- factant protein A in usual interstitial pneumonia compared with non- specific interstitial pneumonia[ J]. Thorax,2003,58:52 - 57.
  • 5Nagata N, Kitasato Y, Wakamatsu K, et al. Prognostic value of im- munohistochemical surfactant protein A expression in regenerative/ hyperplastic alveolar epithelial ceils in idiopathic interstitial pneu- monias[ J]. Diagn Patho1,2011,6:25.
  • 6Vuorinen K, Myllarniemi M, Lammi L, et al. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases [ J ]. APMIS, 2007,115:969 - 975.
  • 7Rosas IO, Richards TJ, Konishi K, et al. MMP1 and MMP7 as po- tential peripheral blood biomarkers in idiopathic pulmonary fibrosis [ J ]. PLoS Med,2008,5 : e93.
  • 8Richards TJ, Kaminski N, Baribaud F, et al. Peripheral blood pro- teins predict mortality in idiopathic pulmonary fibrosis [ J ]. Am J Respir Crit Care Med,2012,185 ( 1 ) :67 - 76.
  • 9Prasse A, Probst C, Bargagli E, et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis [ J ]. Am J Respir Crit Care Mcd,2009,179:717 - 723.
  • 10Meyer KC, Cardoni A, Xiang ZZ. Vascular endothelial growth factorin bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease [ J ]. J Lab Clin Med ,2000,135: 332 -338.

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部